EMA
approval
· 2012-04-20
European Medicines Agency recommends authorisation of novel treatment for type-2 diabetes
Summary
The European Medicines Agency recommends authorisation of a novel treatment for type 2 diabetes, signaling potential new option for management of the disease.
Upgrade for the full analysis, importance score, and drug timeline.